GSK1016790A

CAS No. 942206-85-1

GSK1016790A ( GSK1016790A; GSK-1016790A; GSK 1016790A. )

Catalog No. M19275 CAS No. 942206-85-1

GSK1016790A (GSK101) is a novel, potent activator of TRPV4 (transient receptor potential vanilloid 4) with EC50 of 34 nM in choroid plexus epithelial cells.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 37 In Stock
5MG 59 In Stock
10MG 104 In Stock
25MG 228 In Stock
50MG 345 In Stock
100MG 512 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK1016790A
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK1016790A (GSK101) is a novel, potent activator of TRPV4 (transient receptor potential vanilloid 4) with EC50 of 34 nM in choroid plexus epithelial cells.
  • Description
    GSK1016790A is a TRPV4 agonist that elicits calcium influx in HEK cells expressing mouse or human TRPV4 (EC50s = 18 and 2.1 nM, respectively).
  • Synonyms
    GSK1016790A; GSK-1016790A; GSK 1016790A.
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    hTRPV4; mTRPV4
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    942206-85-1
  • Formula Weight
    655.61
  • Molecular Formula
    C28H32Cl2N4O6S2
  • Purity
    98%
  • Solubility
    DMSO : ≥ 33 mg/mL; 50.33 mM
  • SMILES
    CC(C)C[C@H](NC(=O)C1=CC2=C(S1)C=CC=C2)C(=O)N1CCN(CC1)C(=O)[C@H](CO)NS(=O)(=O)C1=C(Cl)C=C(Cl)C=C1
  • Chemical Name
    N-[(2S)-1-[4-[(2S)-2-[(2,4-dichlorophenyl)sulfonylamino]-3-hydroxypropanoyl]piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-1-benzothiophene-2-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Palosuran hydrochlor...

    Palosuran is a new potent and specific antagonist of the human UT receptor with an IC50 of 3.6±0.2 nM.

  • DS-7423

    DS-7423 is a novel potent, small-molecule dual inhibitor of PI3K/mTOR.

  • BYL-719

    Alpelisib (BYL-719) is a potent and selective PI3Kα inhibitor with IC50 of 5 nM in a cell-free assay, and minimal effect on PI3Kβ/γ/δ. Phase 2.